145 related articles for article (PubMed ID: 32794745)
1. Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent.
Lu X; Liu YC; Orvig C; Liang H; Chen ZF
J Med Chem; 2020 Sep; 63(17):9154-9167. PubMed ID: 32794745
[TBL] [Abstract][Full Text] [Related]
2. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.
Lu X; Liu YC; Orvig C; Liang H; Chen ZF
Eur J Med Chem; 2019 Nov; 181():111567. PubMed ID: 31401535
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.
Lee T; Christov PP; Shaw S; Tarr JC; Zhao B; Veerasamy N; Jeon KO; Mills JJ; Bian Z; Sensintaffar JL; Arnold AL; Fogarty SA; Perry E; Ramsey HE; Cook RS; Hollingshead M; Davis Millin M; Lee KM; Koss B; Budhraja A; Opferman JT; Kim K; Arteaga CL; Moore WJ; Olejniczak ET; Savona MR; Fesik SW
J Med Chem; 2019 Apr; 62(8):3971-3988. PubMed ID: 30929420
[TBL] [Abstract][Full Text] [Related]
4. Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells.
Doi K; Gowda K; Liu Q; Lin JM; Sung SS; Dower C; Claxton D; Loughran TP; Amin S; Wang HG
Cancer Biol Ther; 2014; 15(12):1688-99. PubMed ID: 25535900
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.
Tron AE; Belmonte MA; Adam A; Aquila BM; Boise LH; Chiarparin E; Cidado J; Embrey KJ; Gangl E; Gibbons FD; Gregory GP; Hargreaves D; Hendricks JA; Johannes JW; Johnstone RW; Kazmirski SL; Kettle JG; Lamb ML; Matulis SM; Nooka AK; Packer MJ; Peng B; Rawlins PB; Robbins DW; Schuller AG; Su N; Yang W; Ye Q; Zheng X; Secrist JP; Clark EA; Wilson DM; Fawell SE; Hird AW
Nat Commun; 2018 Dec; 9(1):5341. PubMed ID: 30559424
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity.
Bruncko M; Wang L; Sheppard GS; Phillips DC; Tahir SK; Xue J; Erickson S; Fidanze S; Fry E; Hasvold L; Jenkins GJ; Jin S; Judge RA; Kovar PJ; Madar D; Nimmer P; Park C; Petros AM; Rosenberg SH; Smith ML; Song X; Sun C; Tao ZF; Wang X; Xiao Y; Zhang H; Tse C; Leverson JD; Elmore SW; Souers AJ
J Med Chem; 2015 Mar; 58(5):2180-94. PubMed ID: 25679114
[TBL] [Abstract][Full Text] [Related]
7. Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors.
Lee T; Bian Z; Zhao B; Hogdal LJ; Sensintaffar JL; Goodwin CM; Belmar J; Shaw S; Tarr JC; Veerasamy N; Matulis SM; Koss B; Fischer MA; Arnold AL; Camper DV; Browning CF; Rossanese OW; Budhraja A; Opferman J; Boise LH; Savona MR; Letai A; Olejniczak ET; Fesik SW
FEBS Lett; 2017 Jan; 591(1):240-251. PubMed ID: 27878989
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.
Wan Y; Wang J; Sun F; Chen M; Hou X; Fang H
Bioorg Med Chem; 2015 Dec; 23(24):7685-93. PubMed ID: 26620718
[TBL] [Abstract][Full Text] [Related]
9. Highly Antiproliferative Latonduine and Indolo[2,3-
Wittmann C; Bacher F; Enyedy EA; Dömötör O; Spengler G; Madejski C; Reynisson J; Arion VB
J Med Chem; 2022 Feb; 65(3):2238-2261. PubMed ID: 35104137
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
Liu L; Liu R; Yang X; Hou X; Fang H
Eur J Med Chem; 2020 Apr; 191():112142. PubMed ID: 32088497
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors.
Zhu J; Wang Z; Guo Z; Zhang X; Song T; Guo Y; Ji T; Zhang Z
Arch Pharm (Weinheim); 2020 May; 353(5):e2000005. PubMed ID: 32175625
[TBL] [Abstract][Full Text] [Related]
12. Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.
Shen WY; Jia CP; Mo AN; Liang H; Chen ZF
Eur J Med Chem; 2021 Nov; 223():113636. PubMed ID: 34175540
[TBL] [Abstract][Full Text] [Related]
13. Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo.
Sun JG; Li H; Li X; Zeng X; Wu P; Fung KP; Liu FY
Apoptosis; 2014 May; 19(5):871-82. PubMed ID: 24563182
[TBL] [Abstract][Full Text] [Related]
14. A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.
Abulwerdi F; Liao C; Liu M; Azmi AS; Aboukameel A; Mady AS; Gulappa T; Cierpicki T; Owens S; Zhang T; Sun D; Stuckey JA; Mohammad RM; Nikolovska-Coleska Z
Mol Cancer Ther; 2014 Mar; 13(3):565-75. PubMed ID: 24019208
[TBL] [Abstract][Full Text] [Related]
15. Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.
Rescourio G; Gonzalez AZ; Jabri S; Belmontes B; Moody G; Whittington D; Huang X; Caenepeel S; Cardozo M; Cheng AC; Chow D; Dou H; Jones A; Kelly RC; Li Y; Lizarzaburu M; Lo MC; Mallari R; Meleza C; Rew Y; Simonovich S; Sun D; Turcotte S; Yan X; Wong SG; Yanez E; Zancanella M; Houze J; Medina JC; Hughes PE; Brown SP
J Med Chem; 2019 Nov; 62(22):10258-10271. PubMed ID: 31736296
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.
Wan Y; Dai N; Tang Z; Fang H
Eur J Med Chem; 2018 Feb; 146():471-482. PubMed ID: 29407973
[TBL] [Abstract][Full Text] [Related]
18. S1, a novel pan-BH3 mimetic, induces apoptosis in Mcl-1-overexpressing cells through Bak.
Song T; Chang X; Zhang Z; Liu Y; Shen X
J Pharmacol Sci; 2012; 119(4):330-40. PubMed ID: 22814102
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structure-activity relationship studies of N-substituted indole derivatives as novel Mcl-1 inhibitors.
Luan S; Ge Q; Chen Y; Dai M; Yang J; Li K; Liu D; Zhao L
Bioorg Med Chem Lett; 2017 May; 27(9):1943-1948. PubMed ID: 28343875
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors.
Wan Y; Li Y; Yan C; Wen J; Tang Z
Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
